oa SA Pharmaceutical Journal - New Product Focus - Zostavax® : varicella-zoster virus (live vaccine) : drug info

Volume 81, Issue 3
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Zostavax® is indicated for the immunisation of adults aged 50 years and older to prevent or reduce the severity of herpes zoster (shingles), post-herpetic neuralgia and acute and chronic pain associated with herpes zoster infection.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error